REFERENCES
- Beery AK, Zucker I. Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev 2011;35(3):565–572.
- Marts SA, Keitt S. Foreward: A historical overview of advocacy for research in sex-based biology. Adv Mol Cell Biol 2004;34:v–xiii.
- Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 2009;48(3):143–157.
- Franconi F, Campesi I. Pharmacogenomics, pharmacokinetics and pharmacodynamics: Interaction with biological differences between men and women. Br J Pharmacol 2014;171(3):580–594.
- Berger JS, Elliott L, Gallup D, et al. Sex differences in mortality following acute coronary syndromes. JAMA 2009;302(8):874–882.
- Harrison-Findik DD. Gender-related variations in iron metabolism and liver diseases. World J hepatol 2010;2(8):302–310.
- Frost M, Gudex C, Rubin KH, et al. Pattern of use of DXA scans in men: A cross-sectional, population-based study. Osteoporos Int 2012;23(1):183–191.
- Pal SK, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol 2010;28(26):4086–4093.
- Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 1999;103(2 Pt 1):282–288.
- Kanda N, Tsuchida T, Tamaki K. Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol 1996;106(2):410–415.
- Cyster JG, Goodnow CC. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 1995;2(1):13–24.
- Dinesh RK, Hahn BH, Singh RP. PD-1, gender, and autoimmunity. Autoimmun Rev 2010;9(8):583–587.
- Merino R, Ding L, Veis DJ, et al. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J 1994;13(3):683–691.
- Sato S, Tuscano JM, Inaoki M, Tedder TF. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor. Semin Immunol 1998;10(4):287–297.
- Sthoeger ZM, Chiorazzi N, Lahita RG. Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation. J Immunol 1988;141(1):91–98.
- Nostrati A, Wei ML. Sex disparities in melanoma outcomes: The role of biology. Arch Biochem Biophys 2014;563:42–50.
- Sthoeger ZM, Zinger H, Mozes E. Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies. Ann Rheum Dis 2003;62(4):341–346.
- Fish EN. The X-files in immunity: Sex-based differences predispose immune responses. Nat Rev Immunol 2008;8(9):737–744.
- Amadori A, Zamarchi R, De Silvestro G, et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995;1(12):1279–1283.
- Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4+CD25+and FOXP3 +regulatory T cells during the follicular phase of the menstrual cycle: Implications for human reproduction. J Immunol 2007;178(4):2572–2578.
- Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat Immunol 2008;9(3):239–244.
- Lawson CA, Brown AK, Bejarano V, et al. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. Rheumatology (Oxford) 2006;45(10):1210–1217.
- Mo R, Chen J, Grolleau-Julius A, et al. Estrogen regulates CCR gene expression and function in T lymphocytes. J Immunol 2005;174(10):6023–6029.
- Pernis AB. Estrogen and CD4+ T cells. Curr Opin Rheumatol 2007;19(5):414–420.
- Kramer PR, Winger V, Kramer SF. 17beta-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytes. Mol Cell Endocrinol 2007;279(1–2):16–25.
- Kramer PR, Kramer SF, Guan G. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum 2004;50(6):1967–1975.
- Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update 2005;11(4):411–423.
- Garcia-Duran M, de Frutos T, Diaz-Recasens J, et al. Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils. Circ Res 1999;85(11):1020–1026.
- Miyagi M, Aoyama H, Morishita M, Iwamoto Y. Effects of sex hormones on chemotaxis of human peripheral polymorphonuclear leukocytes and monocytes. J Periodontol 1992;63(1):28–32.
- Hao S, Zhao J, Zhou J, et al. Modulation of 17beta-estradiol on the number and cytotoxicity of NK cells in vivo related to MCM and activating receptors. Int Immunopharm 2007;7(13): 1765–75.
- Seillet C, Rouquie N, Foulon E, et al. Estradiol promotes functional responses in inflammatory and steady-state dendritic cells through differential requirement for activation function-1 of estrogen receptor alpha. J Immunol 2013;190(11):5459–5470.
- Carreras E, Turner S, Frank MB, et al. Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4. Blood 2010;115(2):238–246.
- Siracusa MC, Overstreet MG, Housseau F, et al. 17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic cells. J Immunol 2008;180(3):1423–1431.
- Brooks EG, Schmalstieg FC, Wirt DP, et al. A novel X-linked combined immunodeficiency disease. J Clin Invest 1990;86(5):1623–1631.
- van der Vliet HJ, Nieuwenhuis EE. IPEX as a result of mutations in FOXP3. Clin Dev Immunol 2007;2007:89017.
- Sundar R, Soong R, Cho BC, et al. Immunotherapy in the treatment of non-small cell lung cancer. Lung Cancer (Amsterdam) 2014;85(2):101–109.
- Robert C, Ribas A, Wolchok JD, et al. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial. Lancet 2014;384(9948):1109–1117.
- Lin PY, Sun L, Thibodeaux SR, et al. B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses. J Immunol 2010;185(5):2747–2753.
- Shigematsu Y, Hanagiri T, Shiota H, et al. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer. Lung cancer (Amsterdam) 2010;68(1):105–110.
- Gure AO, Chua R, Williamson B, et al. Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clin Cancer Res 2005;11(22):8055–8062.
- Chiriva-Internati M, Mirandola L, Yu Y, et al. Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapy. J Immunother 2011;34(6):490–499.